Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV: TKUN)

Market Cap	30.75M
Revenue (ttm)	42.55M
Net Income (ttm)	-50.05M
Shares Out	80.92M
EPS (ttm)	-0.87
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,177
Open	38.00
Previous Close	38.00
Day's Range	37.00 - 39.70
52-Week Range	23.00 - 56.60
Beta	0.83
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About TLV: TKUN

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was incorporated in 2023 and is based in Nof HaGalil, Israel.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2023
• Employees: 51
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TKUN

Financial Performance

In 2023, TKUN's revenue was 44.23 million, a decrease of -10.28% compared to the previous year's 49.30 million. Losses were -88.89 million, 84.3% more than in 2022.